Telemedical Assistance in Automatic Titration of Oxygen for Intensive Care Patients (Smartassistant)
Obesity Hypoventilation Syndrome (OHS), Chronic Obstructive Lung Disease, Interstitial Lung Disease
About this trial
This is an interventional diagnostic trial for Obesity Hypoventilation Syndrome (OHS) focused on measuring Telemedicine, Smart assistant
Eligibility Criteria
Inclusion Criteria: signed informed consent to participate in the study; aged over 18 years; patients hospitalized with acute respiratory failure (indication to NIV therapy) with restrictive or obstructive lung disease Exclusion Criteria: refusal to participate further in the study; age under 18 years; pregnancy; the patient is contraindicated for non-invasive lung ventilation during the study, the patients condition worsens in such a way that an active one is required medical intervention or continuation of the study may worsen the patients condition; complications related to NIV therapy or claustrophobia; chronic obstructive pulmonary disease and obstructive sleep apnea without documented hypoxemia (Sp02 and Sa02 > 94%).
Sites / Locations
- Pauls Stradins Clinical Univeristy HospitalRecruiting
Arms of the Study
Arm 1
Experimental
CPAP/APAP INTERVENTION WITH AND WITHOUT OXYGEN SUPPORT
Patients in this group will be selected from the Sleep Disorder Center database for printing data on hypoxemia below 90% during the night and for treatment received (CPAP/APAP and/or oxygen therapy). And from available data in PSCUH data systems on patient diagnoses, previous results of studies (results of blood gas tests), and recommended treatments on hospital and outpatient disease cards, which will include indications of possible chronic hypoxemia. The selected patients will be called (telephone visit) and, if agreed, will be scheduled for study time. Consequently, if the consent questionnaire was signed, a study will be launched following an evaluation of the inclusion and exclusion criteria.